Loading...

The Scientist

» drug development

Most Recent

image: Bioengineers Use Yeast to Manufacture Drugs

Bioengineers Use Yeast to Manufacture Drugs

By Jim Daley | April 3, 2018

The yeast’s output of noscapine, a cough suppressant naturally made by poppies, is 18,000-fold higher than previous attempts.

0 Comments

With three recent FDA approvals, and a number of Phase 3 trials ongoing, the drugs are seeing a surge in interest.

0 Comments

image: Infographic: Cancer Drug Pairings

Infographic: Cancer Drug Pairings

By Anna Azvolinsky | April 1, 2018

Researchers use several different strategies to deliver a one-two punch.

0 Comments

Multidrug combinations lead to better results for cancer patients, but efficiently identifying them is proving difficult.

0 Comments

image: How to Successfully Collaborate with Industry

How to Successfully Collaborate with Industry

By Ashley P. Taylor | March 1, 2018

In efforts to translate basic-science results into pharmaceuticals and other technologies, success cannot be taken for granted.

1 Comment

One dose of the medication, called Xofluza, cripples influenza by interfering with an enzyme critical for viral replication.  

0 Comments

Pharmaceutical giant Sanofi to take over hemophilia drugmaker Biovertiv, while Celgene will buy cancer drugmaker Juno Therapeutics.

0 Comments

image: Opinion: Label Drugs That Are Tested on Animals

Opinion: Label Drugs That Are Tested on Animals

By Shaun Khoo | January 16, 2018

Transparency about the role of animals in drug development could help raise awareness of and appreciation for preclinical research.

1 Comment

image: Child Receives Transgenic Skin

Child Receives Transgenic Skin

By Ruth Williams | January 1, 2018

A combination gene-and-cell therapy has given a boy with a grievous skin disease a new lease on life, and resolved a dermatology debate to boot.

0 Comments

image: Infographic: A Painful Pathway

Infographic: A Painful Pathway

By Catherine Offord | January 1, 2018

Since the mid-2000s, the voltage-gated sodium channel NaV1.7 has emerged as a promising target for a new class of analgesics.

0 Comments

Popular Now

  1. Estonia Offers Free Genetic Testing to Residents
  2. Human Brain Organoids Thrive in Mouse Brains
  3. The Second March for Science a Smaller Affair
  4. RNA Injection Restores Hearing in Guinea Pigs